Skip to content
StockMarketAgent
Sector pending / Hospital and Medical Service PlansUpdated 2026-05-10 22:07 UTC

BIT/1ANTM stock hub

BIT/1ANTM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BIT/1ANTMis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
69.8B
Borsa Italiana
Market data

Live price

Current market quote for this ticker.

Current price
BIT/1ANTM
In the news

Latest news · BIT/1ANTM

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6
P25 n/aP50 n/aP75 n/a
Trailing P/E15.3
P25 n/aP50 n/aP75 n/a
ROE12.1
P25 n/aP50 n/aP75 n/a
ROIC8.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BIT/1ANTM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
199
Groups with data
11
Currency
USD
Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
IT
Employees
96,615
Employees Change
-7,100%
Employees Change Percent
-6.81
Enterprise value
EUR 88.7B
Exchange
Borsa Italiana
Financial currency
USD
First seen
2026-05-10
Industry
Hospital and Medical Service Plans
Last refreshed
2026-05-10
Market cap
EUR 69.8B
Price
EUR 318
Price currency
EUR
Rev Per Employee
1,799,107.77x
Sic
6324
Symbol
bit/1ANTM
Website
https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
6.52%
EV Earnings
19.51x
EV/EBIT
13.36x
EV/EBITDA
12.02x
EV/FCF
15.86x
EV/Sales
0.52x
FCF yield
8.02%
Forward P/E
14.59x
P/B ratio
1.83x
P/E ratio
15.34x
P/S ratio
0.4x
PE Ratio10 Y
16.44x
PE Ratio3 Y
16.31x
PE Ratio5 Y
17.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
3.9%
EBITDA Margin
4.26%
FCF margin
3.22%
Gross margin
25.89%
Gross Profit
EUR 45B
Net Income
EUR 4.5B
Net Income Growth
-11.39%
Net Income Growth Q
-19.19%
Net Income Growth3 Y
-4.89%
Net Income Growth5 Y
2.15%
Pretax Margin
3.1%
Profit Margin
2.62%
Profit Per Employee
EUR 47,066
ROA
3.98
Roa5y
5.41
ROCE
9.71
ROE
12.09
Roe5y
15.57
ROIC
8.63
Roic5y
11.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr1y
-11.27%
Cagr3y
-11.2%
Cagr5y
0.99%
Div CAGR3
5.02%
Div CAGR5
11.8%
EPS Growth
-8.15
EPS Growth Q
-16.75
EPS Growth3 Y
-2.31
EPS Growth5 Y
4.7
FCF Growth
75.56%
FCF Growth Q
399.03%
FCF Growth3 Y
-16.62%
FCF Growth5 Y
-7.75%
OCF Growth
56.9%
OCF Growth Q
325.96%
OCF Growth10 Y
7.11%
OCF Growth3 Y
-14.87%
OCF Growth5 Y
-6.56%
Revenue Growth
9.44x
Revenue Growth Q
2.64x
Revenue Growth3 Y
7.64x
Revenue Growth5 Y
9.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
EUR 1.63
Assets
EUR 109.1B
Cash
EUR 32.2B
Debt
EUR 27.6B
Debt EBITDA
EUR 3.67
Debt Equity
EUR 0.72
Debt FCF
EUR 4.94
Equity
EUR 38.2B
Interest Coverage
5.52
Liabilities
EUR 70.9B
Net Cash
EUR -19.2B
Net Cash By Market Cap
EUR -27.58
Net Debt EBITDA
EUR 2.6
Net Debt Equity
EUR 0.5
Net Debt FCF
EUR 3.44
Tangible Book Value
EUR 3.9B
Tangible Book Value Per Share
EUR 17.83

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
1.48
Net Working Capital
EUR 11.4B
Quick ratio
1.33
Working Capital
EUR 18.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
3.57%
Dividend Growth
-3.11%
Dividend Growth Years
0%
Dividend per share
EUR 5.91
Dividend Years
8
Dividend Yield
1.86%
Ex Div Date
2026-03-09
Last Dividend
EUR 1.48
Payout Frequency
Quarterly
Payout Ratio
28.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
-11.27%
200-day SMA
279.9
3Y total return
-29.98%
50-day SMA
270.7
50-day SMA vs 200-day SMA
50under200
5Y total return
5.05%
All Time High
513.2
All Time High Change
-38%
All Time High Date
2024-09-03
All Time Low
169
All Time Low Change
88.28%
All Time Low Date
2020-03-23
ATR
5.9
Ch YTD
7.14
High52
379.7
High52 Date
2025-05-12
High52ch
-16.2%
Low52
237.1
Low52 Date
2025-07-22
Low52ch
34.21%
Ma50ch
17.54%
Price vs 200-day SMA
13.69%
RSI
70.86
RSI Monthly
46.69
RSI Weekly
60.2
Sharpe ratio
-0.18x
Sortino ratio
-0.11
Total Return
5.43%
Tr YTD
7.79
Tr1m
18.03%
Tr1w
0.25%
Tr3m
14.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 6.8B
Operating margin
3.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
216,661,597%
Net Borrowing
1,561,098,042
Shares Insiders
0.12%
Shares Institutions
96.58%
Shares Qo Q
-0.63%
Shares Yo Y
-3.57%
Short Ratio
2.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
EUR 5.4B
Average Volume
4.6x
Bv Per Share
175.2
CAPEX
EUR -1B
Ch1m
18.03
Ch1w
0.25
Ch1y
-13.13
Ch3m
13.48
Ch3y
-33.6
Ch5y
-2.03
Ch6m
17.55
Change
0.38%
Close
317
Earnings Date
2026-04-22
EBIT
EUR 6.8B
EBITDA
EUR 7.4B
EPS
EUR 20.4
F Score
6
FCF
EUR 5.6B
FCF EV Yield
6.31x
Financing CF
-2,032,951,200
Fiscal Year End
December
Founded
2,001
Goodwill
24,031,243,080
Graham Number
285.17596
Graham Upside
-10.38
Income Tax
EUR 850M
Investing CF
-2,679,089,700
Is Primary Listing
0
Last Earnings Date
2026-04-22
Last Report Date
2026-03-31
Lynch Fair Value
EUR 104
Lynch Upside
-67.41
Ma150
286.2
Ma150ch
11.17%
Ma20
292.2
Ma20ch
8.9%
Net CF
1,870,766,100
Next Earnings Date
2026-07-15
P FCF Ratio
12.47
P OCF Ratio
10.58
Payment Date
2026-03-25
Ppne
3,948,959,034
Price Date
2026-05-08
Price EBITDA
EUR 9.42
Ptbv Ratio
18
Relative Volume
0.43x
Revenue
173,820,796,800x
SBC By Revenue
0.12x
Share Based Comp
216,825,000
Tax By Revenue
0.49x
Tax Rate
15.76%
Tr6m
18.87%
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BIT/1ANTM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.9%
$5.91 annual per share
Payout ratio
+29.0%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+11.8%
0 consecutive years of growth
Total shareholder yield
+5.4%
Next ex-dividend date: 2026-03-09
Performance

BIT/1ANTM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-11.3%
S&P 500 1Y: n/a
3Y total return
-30.0%
S&P 500 3Y: n/a
5Y total return
+5.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BIT/1ANTM?

Insider, institutional, and short-interest positioning.

Institutional ownership
+96.6%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.4 days to cover
Y/Y dilution
-3.6%
Negative means the company is buying back shares.
Technical

BIT/1ANTM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
70.9
Above 70: short-term overbought
Price vs 200-day MA
+13.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.18
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BIT/1ANTM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1ANTM stock rating?

bit/1ANTM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1ANTM analysis?

The full report lives at /stocks/bit/1ANTM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1ANTM?

The latest report frames bit/1ANTM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1ANTM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.